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Abstract
Proteasomes generate peptides from intracellular endogenous and viral proteins for presentation by MHC class I
 .molecules. During viral infection, interferon-g IFN-g acts as a cytokine altering the catalytic specificity of proteasomes
 .by inducing the synthesis of the three proteasome subunits, low molecular weight protein LMP 2, LMP7 and
 .multicatalytic endopeptidase complex-like 1 MECL1 . LMP2 and LMP7 have been shown to favour the presentation of
certain antigenic peptides. These subunits are constitutively expressed in cell lines related to the immune system and
IFN-g-inducible in other cell lines. Less is known about MECL1. To reveal the extent of constitutive and IFN-g-induced
expression of MECL1, we studied MECL1 in different cell lines by Northern and Western blotting. The two B cell lines
IM9 and Reh showed high constitutive expression of MECL1, only slightly induced by IFN-g stimulation. The B cell line
Daudi and the monocyte cell line THP-1 expressed MECL1 constitutively at an intermediate level. The MECL1 protein
level in the THP-1 cells increased markedly in response to IFN-g . In cells unrelated to the immune system, a very low
constitutive expression of MECL1 was detected, highly inducible by IFN-g . These results indicate that, similar to LMP2
and LMP7, MECL1 is constitutively expressed at high levels only in certain cell lines and can be induced by IFN-g in other
cell lines. The differential expression of MECL1 may be of importance for which antigenic peptides are presented by
different cells as well as by the same cells at different IFN-g levels. q 1998 Elsevier Science B.V.
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1. Introduction
Antigenic peptides derived from intracellular pro-
teins are continuously presented to the immune sys-
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tem by MHC class I molecules on the surface of
immune and nonimmune cells. The generation of
most antigenic peptides is dependent on proteasomes
w x1 . As part of the pathway for degradation of ubiqui-
tin-conjugated proteins, proteasomes are the major
nonlysosomal proteolytic enzymes in the cell and
w xdegrade the bulk of cytosolic proteins 2 . Eukaryotic
20S proteasomes are multicatalytic particles with
twofold symmetry composed of 14 different subunits
occupying distinct positions in four superimposed
w xrings 3,4 . The two inner rings are formed by the
0167-4889r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
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b-type subunits, which contain catalytically active
w xsites 4 .
 .Interferon-g IFN-g , a cytokine of major impor-
tance to the immune system during viral infection,
w xalters the subunit composition of the proteasomes 5
w xforming so-called immunoproteasomes 6 . Upon
stimulation of cells with IFN-g , the three constitutive
subunits X, Y and Z are replaced by the IFN-g-in-
ducible proteasome subunits low molecular weight
 .protein LMP 7, LMP2 and multicatalytic endopepti-
 . w xdase complex-like 1 MECL1 , respectively 6–13 .
These six subunits all contain a putative catalytically
w xactive N-terminal threonine 14 and are thereby po-
tential contributors to the catalytic specificity of the
proteasome. IFN-g is shown to modify the peptidase
w xactivities of proteasomes 11,15–18 in a way that
could promote more efficient formation of peptides
w xsuitable for binding to MHC class I molecules 19 .
While not crucial to antigen processing in general
w x20,21 , the importance of the IFN-g-inducible sub-
units LMP2 and LMP7 for supply of antigenic pep-
wtides has been demonstrated in knockout mice 22–
x24 . The altered catalytic activity may not only affect
the amount of antigenic peptides produced but also
the specific sets of peptides generated from the dif-
ferent proteins in the cell. Indeed, processing and
presentation of specific peptides have been shown to
be favoured by the presence of LMP2 and LMP7
w x22–25 . Moreover, in cell lines LMP2-containing
proteasomes are required for presentation of specific
w xinfluenza virus antigens 26 . Thus, the IFN-g-induci-
ble proteasome subunits LMP2 and LMP7 are proba-
bly important for determining the different peptides
generated for presentation by MHC class I molecules.
The third IFN-g-inducible subunit, MECL1, has
been studied in much less detail, but may well be of
importance for the catalytic properties of protea-
somes. While LMP2 and LMP7 are encoded in the
w xMHC class II region 27,28 , the gene for MECL1 is
part of a tight cluster of unrelated genes on human
w xchromosome 16q22.1 29 . In addition to being IFN-g
inducible, MECL1 is constitutively expressed in sev-
w xeral tissues 29 . The aim of the present study was to
reveal the extent of constitutive and IFN-g-induced
expression of MECL1 in different cell lines. Compar-
ison of the constitutive expression with the IFN-g-in-
duced expression of MECL1 may give clues to the
role of MECL1 in antigen processing, both during
normal conditions and during viral infection.
2. Materials and methods
2.1. cDNA cloning
An AMA cell cDNA library in l-ZAPII was
screened for MECL1 cDNA. The cDNA clones of the
library were size-fractionated to 1000–2400 bp, and
cloned between the EcoRI and XhoI sites of the
polylinker. The library was amplified using the E.
 . 5coli Epicurion Coli SURE Stratagene , and 4=10
plaques were screened using the same host. After
plaque-lifting and denaturing, the filters were probed
with a MECL1 cDNA fragment from a previously
screened cDNA library from Daudi cells. This incom-
plete cDNA clone had an intron disrupting the open
reading frame, and was labelled with 32P-nucleotides
w xby random priming 30 . After secondary screening,
positive clones were amplified and zapped using the
helper virus R408, giving pBluescript SKy carrying
the cDNA insert.
The cDNA clones and derived deletion clones
were sequenced from each end using pBluescript
primers. The polylinker enzymes SacII and KpnI
cutting around the middle of the cDNA, were used
for making deletion clones. The cDNA was se-
quenced using an Automated Laser Fluorescent DNA
 .Sequencer Pharmacia and a redundancy of 3.
2.2. Methylation status of CpG island
Genomic DNA extracted from white blood cells
was restricted with the methylation sensitive enzymes
A˝aI, BstUI, HhaI, MluI, SacII, SalI, SmaI, and
XhoI, respectively, in addition to SacI, which cuts on
both sides of the MECL1 CpG island. A 440-bp
MluI fragment of the CpG island was used as probe
w xfor the Southern blots 29 .
2.3. Transcription start sites
Transcription start of the MECL1 gene was deter-
X mined by 5 RACE–PCR RACE being rapid amplifi-
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X .cation of cDNA ends; 5 RACE KIT, Clontech . Two
gene specific reverse primers were designed, the
 Xprimer for cDNA synthesis in exon 4 5 -TAGCTC-
X.CATCTTGGACGCCACCATC-3 and the nested
 XPCR primer at the end of exon 3 5 -GTAGATTTTG-
X.GGGGCGATGAAG-3 . mRNA was isolated from
unstimulated HL-60 cells with magnetic beads as
described below, and the first strand was synthesised
 .using AMV reverse transcriptase Promega . The PCR
products were cloned in the pNEB193 vector New
.England Biolabs using the EcoRI-site in the anchor
primer and the SmaI-site in exon 2, and analysed by
DNA sequencing.
2.4. Expression of MECL1 in the SFV-system
 .The Semliki Forest virus SFV system was used
to express MECL1 cDNA in unstimulated ECV304
cells. MECL1 cDNA was cloned into pSFV1 vector,
where the insert uses its own translation initiation
w xsignal 31 . The cDNA was excised from pBluescript
with BamHI and XhoI, and cloned into the BamHI-
site in pSFV1 using a BamHI-linker.
Virus particles were produced and used for infec-
tion as described in the SFV Expression System
manual. ECV304 cells were infected for 1 h by a 1:5
dilution of the virus stock solution, and subjected to
lysis 20 h later.
2.5. Cell lines and preparation of cell extracts
The human cervix carcinoma cell lines HeLa and
 .HeLa S3 ATCC and human breast adenocarcinoma
 .cell line MCF7 were grown in DMEM Gibco BRL
 .with 10% FCS Gibco BRL , and the human colon
 .adenocarcinoma Caco-2 cells ATCC in DMEM with
15% FCS. The human endothelial cell line ECV304
 .ATCC grew in Medium 199 with 10% FCS. The
human B cells lines, IM9 multiple myeloma; IgG
.  .secreting , Daudi Burkitt’s lymphoma; mature B cell
 .and Reh acute lymphoblastic leukaemia; pre-B cell
cells and the human monocyte cell line THP-1 were
 .all grown in RPMI 1640 Gibco BRL with 10%
FCS. HL-60 leukaemia cells were maintained in
RPMI 1640 using 20% FCS.
A freshly obtained buffy coat from a healthy indi-
vidual was used for preparation of human white
blood cells. The mononuclear white blood cells were
 .isolated using Lymphoprep Nycomed as recom-
mended by the manufacturers. An adherent fraction
of the cells, corresponding to monocytes, was ob-
tained by incubating the isolated cells on tissue cul-
ture plates for 2 h.
Cells were lysed in lysis buffer 50 mM Tris–HCl,
.pH 7.6 at 08C, 150 mM NaCl, 1% NP40 on ice for
30 min. No protease inhibitors were added. Extracts
were centrifuged at 13 000 rpm for 10 min and the
supernatant frozen at y208C for later SDS–PAGE.
2.6. Cytokine stimulation
The IFN-g stimulation conditions were examined
using 0, 25, 50, 100, 200, 400 and 800 Urml for 48
h and 200 Urml for 0, 12, 24, 36, 48 and 72 h. In all
the further experiments, ECV304 cells were stimu-
lated with 200 Urml IFN-g for 48 h prior to lysis.
Other cytokines were examined for stimulating
effect on MECL1 in ECV304 and Caco-2 cells: IL-1
 .  .  .100 Urml , IL-6 400 Urml , TGFb 3 ngrml and
 .TNFa 0.9 mgrml all for 6 and 24 h. ECV304,
Caco-2, HeLa and HeLa S3 cells were submitted to
heat shock for 0.5, 1, 2 and 4 h at 428C.
2.7. Proteasome isolation
Proteasomes were isolated by affinity chromato-
graphy using monoclonal antibodies as described by
w xHendil and Uerkvitz 32 . Monoclonal anti-pro-
teasome antibodies were produced from the MCP-21
w xhybridoma cells 32 kindly provided by Dr. K. Hendil
 .University of Copenhagen . The antibody was pre-
cipitated from the cell culture supernatant by 55%
ammonium sulphate, purified on Protein A–Sep-
harose with high salt and high pH and coupled to
 . w xCNBr-activated Sepharose 4B Pharmacia 33 . Cul-
 8 .tured cells ca. 2=10 cells , either unstimulated or
stimulated with IFN-g , were scraped off and ho-
mogenised with a Potter–Elvehjem homogeniser in
two volumes of 5 mM Tris–HCl, pH 7.6 at 08C, 1
mM EDTA, 5 mM mercaptoethanol. Cellular proteins
 .precipitated by 10% wrv PEG 6000 were subjected
w xto the affinity column and isolated as described 32 .
The eluted proteasomes were desalted on a Sephadex
 .G-25 Fine Pharmacia column with 25 mM Tris–
HCl, pH 7.6 at 08C, concentrated using Centricon-10
 .Amicon to 2 mgrml and frozen at y208C.
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2.8. Antibodies
Rabbit oligoclonal antibodies were raised against a
peptide from the MECL1 sequence: SYSRLPFTAL-
 .GSGQD position 157–171 . The peptide was syn-
thesised using t-BOC chemistry on an ABI instru-
ment and coupled to keyhole limpet haemocyanine
before injection. The rabbit immunoglobulins were
purified on a Protein A-coupled Sepharose Phar-
. w xmacia column 33 , dissolved to 1 mgrml, and used
for immunoblotting.
2.9. Northern blots
mRNA was isolated directly from tissue culture
 .  .cells using magnetic poly dT beads Dynabeads
w x34 . The cells were lysed and the DNA viscosity
reduced by shearing DNA through a 21 gauge needle,
before extracting the mRNA. Isolated mRNA was run
on a denaturing agarose gel and blotted. The filters
were probed with a cDNA fragment covering exon 1
to 5 and a 440-bp MluI fragment from the CpG
w xisland 29 , respectively, and washed using stringent
conditions. The mRNA amounts were checked by
hybridising to a glyceraldehyde-3-phosphate dehy-
drogenase cDNA probe.
2.10. SDS–PAGE and immunoblotting
 .The gels 12% were made according to Laemmli
w x35 , and after separation, electroblotted onto poly-
 .vinylidene fluoride membranes Immobilon-P . Bio-
 .tinylated low molecular weight standards Amersham
were used. The membranes, except for lanes with
molecular weight standards, were blocked with 5%
 .ECL blocking reagent Amersham at 48C for at least
1 h. The rabbit anti-MECL1-peptide antibodies were
used at a predetermined dilution of 1:5000 overnight
 .at 48C. The ECL system Amersham was used for
detection as recommended by the manufacturers.
Horseradish peroxidase-linked donkey–anti-rabbit an-
tibodies and streptavidin–horseradish peroxidase
 .both Amersham were both used at a dilution of
1:5000 for 1–2 h at 48C.
2.11. Two-dimensional gel electrophoresis
The components of proteasomes were separated on
2-D IEFrSDS–PAGE using Immobiline DryStrip pH
3–10 L, 11 cm, and ExcelGel SDS gradient 8–18
 . Pharmacia . The purified proteasome fractions 100
.mg were concentrated by N -gas before loaded. The2
gels were blotted for 30 min in a semidry sandwich
and silver stained. MECL1 was detected on the poly-
vinylidene fluoride membrane as described above.
3. Results
3.1. MECL1 cDNA confirms the predicted protein
sequence
MECL1 genomic DNA was first cloned in our
w xlaboratory 29 . To determine the exons of the MECL1
 .gene also called PSMB10 , we screened a human
cDNA library from AMA cells. Three positive clones
were obtained. Sequencing revealed two identical full
 .length MECL1 cDNA clones EMBL Y13640 and a
third clone starting six basepairs downstream of the
exon 1–exon 2 boundary. The full length cDNA
clone was 996 bp with untranslated 5X and 3X regions
of 88 and 54 bp, respectively, and a polyA-tail of 35
nucleotides. The open reading frame was 819 bp,
corresponding to 273 amino acids. The amino acid
translation of MECL1 cDNA confirmed the protein
sequence predicted from the reported genomic se-
w x  .quence 29 EMBL X71874; SwissProt P40306 ,
containing the propeptide and the conserved residues
w x Xfor processing and proteolytic activity 14 . The 5
part of the MECL1 gene is shown in Fig. 1, including
the first two exons encoding the propeptide and the
processing site. MECL1 cDNA corresponds to eight
small exons varying in size from 59 to 152 bp. The
gene covers 2.3 kb, with introns sized between 85
and 471 bp. There were two base differences between
the cDNA and the genomic sequence; one transition
in the promoter G to A, position 2298 of the ge-
.  . nomic fragment Fig. 1 and another in exon 5 T to
.C in position 3464 . The change in exon 5 does not
 .alter the encoded amino acid Gly151 .
3.2. Various transcription start sites in the unmeth-
ylated CpG island
A 1.7 kb long CpG island covers the first six
w xexons of the MECL1 gene 29 . An unmethylated
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Fig. 1. The promoter and 5X part of the MECL1 gene. The MECL1 gene covers 2.3 kb and contains eight small exons. The exon–intron
boundaries are here shown for the first two exons and introns as marked with open arrows. Only parts of the 208 bp long intron 1 are
shown. The filled arrowhead indicates the start of the full length cDNA clone, and an open asterisk marks one of the two polymorphisms
 .found in the cDNA sequence G to A . The derived MECL1 protein sequence is given in one-letter code beneath the nucleotide sequence
 .starting from translation initiation code ATG in position 2345. A vertical black bar indicates the conserved processing site of active
b-type proteasome subunits, and a filled asterisk marks the resulting putative catalytically active N-terminal threonine. All CpG
dinucleotides are underlined showing the first part of the CpG island. The 5X transcriptional start sites found using 5XRACE are shown
with black arrows, the wider arrow marking the start site found in four of six analysed 5XRACE-clones. The SmaI site shown was used for
cloning 5XRACE-products, and is also one of the sites used in analysing the methylation of CpG dinucleotides. Different sequences
w x  . w x similar to promoter elements are boxed: Sp1 site 37 , GAS IFN-g activation site; consensus TTNCNNNAA 40 , ISRE interferon-
 .  . .  . .. w x stimulated response element; consensus G A AAA GrC TrC GAAA GrC TrC 41 , IRE interferon response element; consensus
 . . .  .. w x C ArT GrT GrT ANN CrT 42 and GATE-like 68% identity in position 4–22 of the reported g-activated transcriptional element;
X X. w x  .5 -CCGGAGAGAATTGAAACTTAGGG-3 43 . Another Sp1 binding sequence was found in intron 1 not shown . Base numbering is
 . w xaccording to the 13.9 kb genomic sequence EMBL X71874 29 .
status of a CpG island is often associated with active
transcription in the region. DNA from six different
tissues has previously been shown to be unmeth-
ylated at the three CpG dinucleotides covered by the
w xmethylation sensitive enzyme HpaII 29 . By restric-
tion of DNA from white blood cells using eight
different methylation sensitive enzymes, we increased
the number of examined CpGs to 16 of the 125 CpGs
in the CpG island and found them all to be unmeth-
 . ylated data not shown . One additional site position
.3723–4 at the end of the island was partly meth-
ylated, which is not unusual at the borders of CpG
w xislands 36 .
To define the promoter region, the transcription
start of MECL1 was examined by 5XRACE. mRNA
isolated from HL-60 cells was used, and six different
clones of the PCR-product were sequenced. They
were found to correspond to three different transcrip-
tion start sites, all within the CpG island, resulting in
5X-untranslated mRNA sequences of 69, 81 and 101
 .bp, respectively Fig. 1 . A number of different tran-
scription start sites are regularly seen for genes asso-
ciated with unmethylated CpG islands. As often seen
in these CpG rich promoters, there were no clear
consensus sequences for TATA- or CAAT-boxes up-
stream of the transcription start sites. However, Sp1
w x  .binding sequences 37 were found Fig. 1 . The
MECL1 promoter sequence was also examined for
sequence elements associated with IFN-g stimula-
tion. Induction of genes by IFN-g depends on the
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STAT1 protein signal transducers and activators of
. w xtranscription 38,39 , which in its phosphorylated
form can bind directly to IFN-g activation sites
 . w xGAS 40 . GAS-like sequences were found not far
from the transcription start region of MECL1 Fig.
.1 . Also, two sequences with homology to the inter-
 .feron-stimulated response element ISRE , to which
 .members of the interferon regulatory factor IRF
w xfamily will bind 41 , were observed close to the
 .transcription start sites Fig. 1 . Moreover, sequences
 .homologous to the interferon response elements IRE
w xreported in promoters of MHC class II genes 42
were present in the MECL1 promoter region. Re-
cently, the IFN-g induction of the murine
 .interferon-stimulated gene factor 3g ISGF3grp48
gene was found to be mediated by novel factors
 .binding a g-activated transcriptional element GATE
w x43 . A sequence similar to the GATE sequence was
also found in the MECL1 promoter, covering both
the major transcriptional start site and the beginning
 .of the cDNA clone Fig. 1 . The presence of these
sequences in the MECL1 promoter suggests regulated
transcription of the MECL1 gene.
3.3. Constituti˝e and IFN-g-induced transcription of
MECL1
We have previously detected MECL1 transcription
w xin each of eight human tissues examined 29 . The
highest MECL1 mRNA level was found in spleen,
suggesting high constitutive expression of MECL1 in
immune-related cells. To study the constitutive
MECL1 transcription and the effect of IFN-g stimu-
lation on MECL1 expression, we tested three differ-
 .ent B cell lines IM9, Daudi and Reh and two cell
lines unrelated to the immune system HeLa and
.  .MCF7 Fig. 2 . The level of MECL1 mRNA in
unstimulated cells varied markedly between the dif-
ferent cell lines. In the unstimulated B cell lines IM9
and Reh, the level of MECL1 mRNA was consider-
ably higher than in unstimulated HeLa and MCF7
cells. In response to IFN-g , MECL1 mRNA in-
creased in both HeLa and MCF7 cells, in HeLa
reaching the range of the constitutive mRNA level in
unstimulated IM9 and Reh cells. The corresponding
IFN-g stimulation of IM9 and Reh resulted in a
relatively small increase of MECL1 mRNA. The
Daudi cells behaved differently from the other cell
Fig. 2. Constitutive and IFN-g-induced MECL1 mRNA in differ-
ent cell lines. MECL1 mRNA signals were detected on a North-
 .ern blot of mRNA isolated from different unstimulated y and
 .IFN-g stimulated q cell lines by hybridising to a part of
 .MECL1 cDNA upper panel . The cell lines were stimulated with
IFN-g at a concentration of 200 Urml for 48 h. The same
hybridisation pattern was obtained using a genomic probe from
the MECL1 CpG island. The size of the MECL1 transcript was
1.2 kb. Hybridisation signals obtained using a glyceraldehyde-3-
 .phosphate dehydrogenase GAPDH specific probe on the same
blot are shown in the lower panel.
lines, expressing MECL1 at an intermediate level and
showing hardly any difference between unstimulated
 .and stimulated cells Fig. 2 . These results suggest
that the constitutive MECL1 transcription in IM9 and
Reh cell lines is close to the maximum level of
MECL1 transcription induced by IFN-g .
3.4. IFN-g-induction of MECL1 protein and post-
translational processing
The induction of MECL1 protein by IFN-g was
analysed using Western blotting. Rabbit antibodies
were raised against a peptide in the MECL1 se-
quence. Different human cell lines were examined for
IFN-g-induced increase of MECL1 protein. Induction
of MECL1 protein from an undetectable level in
unstimulated cells, was found in the cell lines HeLa,
HeLa S3, Caco-2, and ECV304, as shown for
 .ECV304 in Fig. 3 lanes 2 and 4 . Different IFN-g
 .concentrations 25 to 800 Urml and stimulation
 .periods 12 to 72 h were tested on ECV304 cells.
The amount of MECL1 protein showed a graded
increase with both IFN-g concentration and stimula-
 .tion time data not shown . For subsequent experi-
ments we used conditions providing maximum induc-
 .tion 200 Urml for 48 h . The IFN-g-induced protein
band was estimated by SDS–PAGE to correspond to
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Fig. 3. Processing and incorporation of IFN-g-induced MECL1
protein into proteasomes in ECV304 cells. Lane 1, biotinylated
low molecular weight standard; lane 2, extract of unstimulated
ECV304 cells; lane 3, extract of ECV304 cells infected with
SFV–MECL1 cDNA; lane 4, extract of IFN-g-stimulated
ECV304 cells; lane 5, proteasomes purified from unstimulated
cells; lane 6, proteasomes purified from IFN-g-stimulated cells.
ECV304 cells were stimulated with 200 Urml IFN-g for 48 h. 5
 .ml 8 mg protein of each cell extract and 2 mg purified
proteasomes were loaded on the gel. MECL1 protein bands were
detected by polyclonal anti-peptide antibodies.
 .a molecular mass of 25.1 kDa Fig. 3, lane 4 . To
compare the size of IFN-g-induced MECL1 with
unprocessed MECL1, we expressed full-length
MECL1 in ECV304 cells by the SFV expression
system, where the endogenous protein synthesis is
inhibited. In this system, MECL1 protein was de-
tected by the antibodies at an apparent molecular
 .mass of 28.8 kDa Fig. 3, lane 3 . These results
suggest that the IFN-g-induced MECL1 protein was
processed, consistent with the finding that MECL1
protein is processed at the processing site in the
 . w xamino acid sequence G-TT 6 , reducing the theoret-
ical mass of the protein from 28958 to 24589 Da.
To investigate if the induction by IFN-g was
specific, the effect of other cytokines and heat shock
on MECL1 expression was tested in the low-ex-
pressing cell lines ECV304 and Caco-2. The cells
were subjected to stimulation by IL-1, IL-6, TNFa ,
or TGFb , or to heat shock at 428C. No detectable
MECL1 increase was found in the Western blots for
 .any of these treatments data not shown .
3.5. Incorporation of IFN-g-induced MECL1 into
proteasomes
To show that IFN-g-induced MECL1 was incorpo-
rated into proteasome particles, we isolated 20S pro-
teasomes from both unstimulated and IFN-g-treated
ECV304 cells by affinity chromatography. Protea-
somes purified from unstimulated cells contained
 .small amounts of MECL1 Fig. 3, lane 5 , not de-
 .tectable in the whole cell extract Fig. 3, lane 2 . The
proteasomes from IFN-g-stimulated cells showed a
 .dramatic increase in MECL1 content Fig. 3, lane 6 .
The purified proteasomes were also subjected to 2-D
 .IEFrSDS–PAGE gels Fig. 4 . The position of
MECL1 protein in the 2-D gel patterns Fig. 4A and
. B was determined by immunoblotting Fig. 4C and
.D . The anti-MECL1 antibodies detected only one
 .proteasome subunit Fig. 4C and D . Corresponding
to this position, a protein spot was seen after silver
staining in proteasomes from IFN-g treated cells
 .  .Fig. 4B but not from untreated cells Fig. 4A .
Fig. 4. MECL1 detection in proteasomes on 2-D gel. Proteasomes from unstimulated and IFN-g stimulated ECV304 cells were analysed
 .  .  .on 2-D IEFrSDS–PAGE by silver staining A and B and anti-MECL1 antibodies C and D . Proteins separated from pH 4 left to pH 9
 .  .  .right and from 32 top to 20 bottom kDa are included.
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Thus, MECL1 protein content of proteasomes seemed
to increase markedly after IFN-g stimulation. Other
changes following IFN-g treatment could also be
seen, but only MECL1 was subjected to identifica-
tion.
3.6. Constituti˝e expression of MECL1 protein
We then examined whether the constitutive
 .MECL1 mRNA level seen in B cell lines Fig. 2 was
expressed at the protein level. Reh and Daudi cells
were stimulated with IFN-g , and the extracts of
unstimulated and stimulated cells analysed by West-
 .ern blotting Fig. 5, lanes 1–4 . The IM9 cells show-
 .ing similar MECL1 mRNA levels as Reh Fig. 2 ,
were not tested for MECL1 protein. The Reh cells
showed constitutive expression of MECL1 protein,
increasing only slightly in response to IFN-g Fig. 5,
.lanes 1 and 2 . Daudi cells also expressed MECL1
protein constitutively but at a lower level, showing no
 .induction by IFN-g Fig. 5, lanes 3 and 4 . Thus, the
MECL1 protein levels correspond well with mRNA
levels in these two B cell lines.
We also examined a monocyte cell line, THP-1,
for constitutive and IFN-g-induced expression of
Fig. 5. Constitutive and IFN-g-induced MECL1 protein in differ-
ent cell extracts. Lane 1, extract of unstimulated Reh cells; lane
2, IFN-g-stimulated Reh cells; lane 3, unstimulated Daudi cells;
lane 4, IFN-g-stimulated Daudi cells; lane 5, unstimulated THP-1
cells; lane 6, IFN-g-stimulated THP-1 cells; lane 7, ECV304 cells
grown in Reh-conditioned RPMI 1640 medium for 48 h; lane 8,
ECV304 cells grown in RPMI 1640 containing IFN-g ; lane 9,
freshly isolated human white blood cells; lane 10, a fraction of
the white blood cells isolated by adhering to tissue culture plates.
 .The position of the MECL1 band marked by an arrow was
consistent with processed MECL1. 8 mg protein extract was
loaded in each lane. IFN-g treatment was performed using 200
Urml for 48 h. MECL1 was detected in different cell extracts by
anti-MECL1 antibodies. The band seen above the MECL1 band
 .in the THP-1 cells lanes 5 and 6 corresponded to a strong cell
line-specific protein band with estimated molecular weight simi-
lar to unprocessed MECL1, but may be unspecific.
 .MECL1 protein Fig. 5, lanes 5 and 6 . In the
unstimulated THP-1 cells MECL1 protein was pre-
 .sent at an intermediate level Fig. 5, lane 5 , similar
 .to the level seen in Daudi cells lane 3 . IFN-g
stimulation of the THP-1 cells resulted in high ex-
 .pression of MECL1 protein Fig. 5, lane 6 , similar to
that detected for Reh cells.
In all these cell lines, the apparent molecular mass
of MECL1 protein was similar to the molecular mass
of the processed form of MECL1 found in protea-
 .some particles from ECV304 cells Fig. 3 . As active
b-type subunits are processed at assembly of the
w xproteasome particles 4,44,45 , processed proteasome
subunits that are not incorporated into proteasomes
are normally not found in the cell. Thus, the constitu-
tively expressed MECL1 protein in these cell lines is
likely to be processed and incorporated into protea-
some particles, in analogy with the incorporation of
MECL1 into proteasomes of stimulated ECV304 cells.
We can, therefore, assume that cell lines with high
constitutive MECL1 expression contain more protea-
somes with MECL1 than other cell lines.
Conceivably, autocrine or paracrine factors re-
leased to the media by monocyte and B cell lines
could explain the high constitutive expression of
MECL1 in these cell lines. We tested this possibility
by growing ECV304 cells in RPMI 1640 and Medium
199 media conditioned by Reh, Daudi and THP-1
cells, respectively. No induction of MECL1 was de-
tected Fig. 5, lane 7 for Reh-conditioned RPMI 1640
.medium . As a positive control, ECV304 cells grown
in RPMI 1640 medium showed normal induction of
 .MECL1 by IFN-g Fig. 5, lane 8 . Therefore, the
constitutive expression of MECL1 in Reh, Daudi and
THP-1 cells could not be explained by a diffusible
and transferable factor released by these cells to the
medium, although we can not exclude that ECV304
may lack receptors for such factors.
Finally, we examined human white blood cells for
the level of MECL1 protein. Mononuclear cells were
isolated from buffy coat of freshly donated blood.
Both the white blood cells and the monocyte fraction
of these, isolated by adhering to tissue culture plates,
were subjected to Western blotting Fig. 5, lanes 9
.and 10 . Both fractions showed a strong MECL1
protein signal, suggesting that MECL1 is constitu-
tively expressed also in normal human white blood
cells.
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4. Discussion
MECL1 was found to be expressed at different
levels in different cell lines. Cell lines unrelated to
the immune system showed generally very low con-
stitutive levels but markedly increased expression
upon stimulation with IFN-g . B cell lines showed
high constitutive expression levels and small effect of
IFN-g . A monocyte cell line showed both constitu-
tive expression of MECL1 and IFN-g inducibility.
The differences in constitutive and IFN-g-induced
expression of MECL1 were demonstrated both at the
mRNA and the protein level. It is therefore likely that
the regulation of MECL1 in these cell lines is differ-
ent and may be functionally important.
The IFN-g-induction of MECL1 has previously
been shown in various nonimmune cell lines, both in
human cells HeLa and two renal carcinoma cell
. w x w xlines 6 and in the murine B8 fibroblast 12 and H6
w xhepatoma cells 13 . These cell lines all showed a low
or not detectable constitutive level of MECL1, con-
sistent with our results.
A major question is whether the difference we
observed for constitutive MECL1 expression is pre-
sent only in cell lines or whether it is also valid for
cells in the human body. Although this question was
not addressed in detail in the present study, we
obtained some evidence that at least some white
blood cells in the human body show a high constitu-
tive expression of MECL1. Our group previously
reported the expression of MECL1 mRNA in various
human tissues adrenal gland, spleen, lung, ileum,
. w xjejunum, pancreas and liver 29 . Possibly, some of
the detected MECL1 mRNA may stem from aggre-
gates of lymphoid cells contained in some of these
tissues. This is supported by the recent reports of
MECL1 being expressed at high levels in murine
w xspleen, thymus and lymph nodes 46 and in bovine
w xspleen 47 .
The observed expression pattern of MECL1 may
in part be explained by the promoter sequence of the
MECL1 gene. The MECL1 gene contains an unmeth-
ylated CpG island which covers the first six of the
 w x .eight exons Ref. 29 and this study . Unmethylated
CpG islands are often, but not exclusively, associated
with ‘housekeeping’ genes, consistent with a wide
constitutive expression at a low level. Close to the
transcriptional start region, several sequences were
identified that may contribute to the regulation of
MECL1 gene expression. The IFN-g-induction of
MECL1 could be mediated through STAT1 binding
to the GAS-like sequences. However, this is unlikely
because of the time course of induction. Rather, since
MECL1 was induced only after hours of stimulation
with IFN-g , other sequences might potentially be
involved through cascades following STAT1 activa-
tion. For instance, an ISRE element was found to
mediate the IFN-g induction of the immunoprotea-
some subunit LMP2 by binding the IFN-g-inducible
w xIRF-1 48,49 . In addition to being involved in the
IFN-g induction pathway, STAT1 might also be
responsible for the high constitutive expression of
MECL1 found in B cell lines. In fact, STAT1 protein
has been reported to be constitutively active in pe-
ripheral blood cells from leukaemia patients and in
Epstein–Barr virus-related lymphoma cell lines, in-
w xcluding Daudi cells 50 . However, whereas no con-
stitutive STAT1-DNA binding activity was detected
in nuclei from mononuclear cells of healthy individu-
w xals in that study 50 , we found high expression of
MECL1 in peripheral blood cells, suggesting that
other mechanisms may be responsible in normal blood
cells. Interestingly, the two IRF family members
interferon consensus sequence binding protein
 . ICSBP and lymphocyte-specific IRF LSIRFrIRF-
.4rPip are expressed mainly in cells of the immune
w xsystem 51–53 , with particularly high expression of
w xLSIRFrIRF-4rPip in B cells 53 . In light of the
various functional combinations of the IRF family
w xmembers 54 , the lymphocyte-specific expression of
certain IRFs might be relevant for the constitutive
expression of MECL1 in B cell lines. Functional
studies of the MECL1 promoter are needed, however,
to reveal the regulatory mechanisms involved.
Interestingly, MECL1 showed similar expression
pattern as the other immunoproteasome subunits
LMP2 and LMP7. As MECL1, these subunits are
expressed at a low level in cells unrelated to the
immune system and are induced by IFN-g in these
w xcells 55–57 . Moreover, in tissues and cells related
to the immune system LMP2 and LMP7 are found at
high constitutive levels, as shown for murine spleen
w x w xand thymus 58 , the B cell line 721.45 18,59 , the
murine T cell line RMA and the murine macrophage
w xcell line RHW 58 . Thus, MECL1, LMP2 and LMP7
are all IFN-g-inducible proteasome subunits with par-
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ticularly high constitutive expression in different im-
mune-related cells. Further studies are needed to
elucidate the possible importance of the concerted
regulation of MECL1, LMP2 and LMP7 in the func-
tions of the immune system.
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